Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma Meeting Abstract
| Authors: | Oki, Y.; Fanale, M. A.; Romaguera, J. E.; Fayad, L.; Fowler, N.; Copeland, A. R. M.; Samaniego, F.; Kwak, L. W.; Neelapu, S. S.; Wang, M.; Feng, L.; Younes, A. |
| Abstract Title: | Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233805123 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.3093.3093 |
| Notes: | Meeting Abstract: 3093 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
